Refine
Document Type
- Article (7)
Has Fulltext
- yes (7)
Is part of the Bibliography
- no (7)
Keywords
- Active middle ear implants (1)
- Auditory system (1)
- Bone conduction devices (1)
- Consensus statement (1)
- Crohn’s disease (1)
- Ellenberg indicator value (1)
- GWAS (1)
- Gap Light Analyzer (1)
- Gene expression (1)
- Health policy (1)
Institute
- Medizin (6)
We show that, under in vitro conditions, the vulnerability of astroglia to hypoxia is reflected by alterations in endothelin (ET)-1 release and capacity of erythropoietin (EPO) to regulate ET-1 levels. Exposure of cells to 24 h hypoxia did not induce changes in ET-1 release, while 48–72 h hypoxia resulted in increase of ET-1 release from astrocytes that could be abolished by EPO. The endothelin receptor type A (ETA) antagonist BQ123 increased extracellular levels of ET-1 in human fetal astroglial cell line (SV-FHAS). The survival and proliferation of rat primary astrocytes, neural precursors, and neurons upon hypoxic conditions were increased upon administration of BQ123. Hypoxic injury and aging affected the interaction between the EPO and ET systems. Under hypoxia EPO decreased ET-1 release from astrocytes, while ETA receptor blockade enhanced the expression of EPO mRNA and EPO receptor in culture-aged rat astroglia. The blockade of ETA receptor can increase the availability of ET-1 to the ETB receptor and can potentiate the neuroprotective effects of EPO. Thus, the new therapeutic use of combined administration of EPO and ETA receptor antagonists during hypoxia-associated neurodegenerative disorders of the central nervous system (CNS) can be suggested.
Das Monitoring von Ökosystemeigenschaften leistet einen wichtigen Beitrag zur Renaturierung von Ökosystemen. Dabei ist es entscheidend, nicht nur Vegetationsdaten, sondern auch Standortfaktoren, wie zum Beispiel Licht, direkt zu erfassen. Das Projekt "Dynamisierung der Donauauen zwischen Neuburg und Ingolstadt" (Bayern) wurde mit der Zielsetzung implementiert, das typische Flutungsregime und die damit verbundenen Grundwasserschwankungen eines naturnahen Auwaldes wiederherzustellen. Ein Teilprojekt des darauf abgestimmten Monitoringprogramms konzentriert sich seit 2007 auf die Beobachtung von Vegetationsveränderungen an einem neu angelegten Umgehungsgewässer, die entlang von rechtwinklig zum Gewässer verlaufenden Transekten erfasst werden. Hierbei wurde der Standortfaktor Licht anhand der sogenannten "Wörlein-Skala" abgeschätzt. Das Ziel dieser Arbeit war es, eine quantitative Methode auf der Basis der digitalen Hemisphärenphotographie zu entwickeln, die genauere Ergebnisse als die Schätzung liefert und dabei zeitsparend und flexibel eingesetzt werden kann. Aufgrund der so erhobenen Daten sollten folgende Fragen beantwortet werden: (1) Liefert die Wörlein-Skala im Vergleich zu den Messdaten eine verlässliche Datengrundlage? (2) Stellen Ellenberg-Lichtzeigerwerte eine sinnvolle Alternative zur direkten Messung oder Schätzung des Standortfaktors Licht dar? In einer Vorstudie wurde die Vergleichbarkeit spezieller Kameraaufbauten unter verschiedenen Umweltbedingungen getestet. Die Bearbeitung der digitalen Photographien erfolgte mit dem Programm "SideLook" zur Schwellenwertermittlung und der Modellierungssoftware "Gap Light Analyzer". Die Prüfung der Verlässlichkeit der Wörlein-Skala und der Ellenberg-Zeigerwerte erfolgte anhand von induktiver Statistik. Der Methodenvergleich ergab deutliche Unterschiede in der Erfassung des Standortfaktors Licht im Auwald: Die Wörlein-Skala repräsentierte die aus den Photographien abgeleiteten Messwerte relativ gut, nur die Schätzungen für die schattigeren Bereiche waren weniger gut aufgelöst. Die Ellenberg-Lichtzeigerwerte korrelierten nur schwach mit den Messwerten sowohl bei logarithmischer Korrektur der Deckung, als auch bei Gewichtung entsprechend der Deckung der Pflanzenarten. Zusammenfassend erfüllt die digitale Hemisphärenphotographie die meisten Anforderungen an Messungen des Standortfaktors Licht. Die Wörlein-Skala kann als verlässliche Alternative betrachtet werden, solange ihr logarithmischer Verlauf entsprechend des Weber-Fechner`schen Gesetzes beachtet wird. Der Ellenberg-Zeigerwert eignet sich dagegen weniger zur Erfassung des Standortfaktors Licht in Auwaldgebieten.
Nowadays, several options are available to treat patients with conductive or mixed hearing loss. Whenever surgical intervention is not possible or contra-indicated, and amplification by a conventional hearing device (e.g., behind-the-ear device) is not feasible, then implantable hearing devices are an indispensable next option. Implantable bone-conduction devices and middle-ear implants have advantages but also limitations concerning complexity/invasiveness of the surgery, medical complications, and effectiveness. To counsel the patient, the clinician should have a good overview of the options with regard to safety and reliability as well as unequivocal technical performance data. The present consensus document is the outcome of an extensive iterative process including ENT specialists, audiologists, health-policy scientists, and representatives/technicians of the main companies in this field. This document should provide a first framework for procedures and technical characterization to enhance effective communication between these stakeholders, improving health care.
In the current study we compared the molecular signature of expanded mesenchymal stromal cells (MSCs) derived from selected CD271+ bone marrow mononuclear cells (CD271-MSCs) and MSCs derived from non-selected bone marrow mononuclear cells by plastic adherence (PA-MSCs). Transcriptome analysis demonstrated for the first time the upregulation of 115 and downregulation of 131 genes in CD271-MSCs. Functional enrichment analysis showed that the upregulated genes in CD271-MSCs are significantly enriched for extracellular matrix (tenascin XB, elastin, ABI family, member 3 (NESH) binding protein, carboxypeptidase Z, laminin alpha 2 and nephroblastoma overexpressed) and cell adhesion (CXCR7, GPNMB, MYBPH, SVEP1, ARHGAP6, TSPEAR, PIK3CG, ABL2 and NCAM1). CD271-MSCs expressed higher gene transcript levels that are involved in early osteogenesis/chondrogenesis/adipogenesis (ZNF145, FKBP5). In addition, increased transcript levels for early and late osteogenesis (DPT, OMD, ID4, CRYAB, SORT1), adipogenesis (CTNNB1, ZEB, LPL, FABP4, PDK4, ACDC), and chondrogenesis (CCN3/NOV, CCN4/WISP1, CCN5/WISP2 and ADAMTS-5) were detected. Interestingly, CD271-MSCs expressed increased levels of hematopoiesis associated genes (CXCL12, FLT3L, IL-3, TPO, KITL). Down-regulated genes in CD271-MSCs were associated with WNT and TGF-beta signaling, and cytokine/chemokine signaling pathways. In addition to their capacity to support hematopoiesis, these results suggest that CD271-MSCs may contain more osteo/chondro progenitors and/or feature a greater differentiation potential.
Apheresis therapies for NMOSD attacks : a retrospective study of 207 therapeutic interventions
(2018)
Objective: To analyze whether 1 of the 2 apheresis techniques, therapeutic plasma exchange (PE) or immunoadsorption (IA), is superior in treating neuromyelitis optica spectrum disorder (NMOSD) attacks and to identify predictive factors for complete remission (CR).
Methods: This retrospective cohort study was based on the registry of the German Neuromyelitis Optica Study Group, a nationwide network established in 2008. It recruited patients with neuromyelitis optica diagnosed according to the 2006 Wingerchuk criteria or with aquaporin-4 (AQP4-ab)-antibody–seropositive NMOSD treated at 6 regional hospitals and 16 tertiary referral centers until March 2013. Besides descriptive data analysis of patient and attack characteristics, generalized estimation equation (GEE) analyses were applied to compare the effectiveness of the 2 apheresis techniques. A GEE model was generated to assess predictors of outcome.
Results: Two hundred and seven attacks in 105 patients (87% AQP4-ab-antibody seropositive) were treated with at least 1 apheresis therapy. Neither PE nor IA was proven superior in the therapy of NMOSD attacks. CR was only achieved with early apheresis therapy. Strong predictors for CR were the use of apheresis therapy as first-line therapy (OR 12.27, 95% CI: 1.04–144.91, p = 0.047), time from onset of attack to start of therapy in days (OR 0.94, 95% CI: 0.89–0.99, p = 0.014), the presence of AQP4-ab-antibodies (OR 33.34, 95% CI: 1.76–631.17, p = 0.019), and monofocal attack manifestation (OR 4.71, 95% CI: 1.03–21.62, p = 0.046).
Conclusions: Our findings suggest early use of an apheresis therapy in NMOSD attacks, particularly in AQP4-ab-seropositive patients. No superiority was shown for one of the 2 apheresis techniques.
Classification of evidence: This study provides Class IV evidence that for patients with NMOSD, neither PE nor IA is superior in the treatment of attacks.
A recent randomized study of whipworm Trichuris suis ova (TSO) in ileal Crohn’s disease failed to demonstrate a clinical benefit compared to placebo after 12 weeks. Nonetheless, it has recently been shown that the spontaneous small intestinal inflammatory changes in Nod2-/- (Nucleotide-binding oligomerization domain 2) mice could be substantially ameliorated when these mice were colonized by Trichuris muris. Those and complementary epidemiologic findings in humans lead to the hypothesis that helminths may be advantageous only in patients carrying defective NOD2 variants. Thus, 207 participants of the TSO trial were retrospectively genotyped for six functional NOD2 genetic variants to evaluate whether the treatment outcome differed in patients carrying NOD2 variants. We observed no significant association of the NOD2 variants or their haplotypes with clinical outcome after TSO treatment.
Aim: Pharmacoresistance is a major burden in epilepsy treatment. We aimed to identify genetic biomarkers in response to specific antiepileptic drugs (AEDs) in genetic generalized epilepsies (GGE). Materials & methods: We conducted a genome-wide association study (GWAS) of 3.3 million autosomal SNPs in 893 European subjects with GGE – responsive or nonresponsive to lamotrigine, levetiracetam and valproic acid. Results: Our GWAS of AED response revealed suggestive evidence for association at 29 genomic loci (p <10-5) but no significant association reflecting its limited power. The suggestive associations highlight candidate genes that are implicated in epileptogenesis and neurodevelopment. Conclusion: This first GWAS of AED response in GGE provides a comprehensive reference of SNP associations for hypothesis-driven candidate gene analyses in upcoming pharmacogenetic studies.